Madan Gopal Kundu

Madan Gopal Kundu

Daiichi-Sankyo Co., Ltd - Tokyo / Japan
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 4468671
person_outline Madan Gopal Kundu's MOST POPULAR ARTICLES
1-) Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trialV Diéras, HS Han, B Kaufman, H Wildiers, M Friedlander, JP Ayoub, ...The lancet oncology 21 (10), 1269-1282, 20201532020
2-) Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trialAB Lassman, SL Pugh, TJC Wang, K Aldape, HK Gan, M Preusser, ...Neuro-oncology 25 (2), 339-350, 202378*2023
3-) refund: Regression with functional dataC Crainiceanu, P Reiss, J Goldsmith, L Huang, L Huo, F Scheipl, ...R package version 0.1-6, 2012782012
4-) The effect of water activity and storage temperature on the growth of Aspergillus flavus in medicinal herbsR Kulshrestha, CP Gupta, G Shukla, MG Kundu, SP Bhatnagar, ...Planta medica 74 (10), 1308-1315, 2008432008
5-) Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of …HS Han, BK Arun, B Kaufman, H Wildiers, M Friedlander, JP Ayoub, ...Annals of Oncology 33 (3), 299-309, 2022312022